Last reviewed · How we verify
Low-grade B cell non-Hodgkin lymphoma
Approved treatments
- Fludara · Nihon Schering K.K.
Fludara works by interfering with the production of DNA and RNA in cancer cells, ultimately leading to cell death. - Fludarabin · Azienda Ospedaliera San Giovanni Battista
- Fludara · Celyad Oncology SA
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Low-grade B cell non-Hodgkin lymphoma patent landscape — cliff calendar, originator estates, attackable patents
- Low-grade B cell non-Hodgkin lymphoma treatment landscape brief
- Low-grade B cell non-Hodgkin lymphoma treatment updates RSS
Frequently asked questions about Low-grade B cell non-Hodgkin lymphoma
What drugs treat Low-grade B cell non-Hodgkin lymphoma?
Tracked treatments include Fludara, Fludarabin.
What is the treatment for Low-grade B cell non-Hodgkin lymphoma?
Standard treatment for Low-grade B cell non-Hodgkin lymphoma includes Fludara, Fludarabin. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: Low-grade B cell non-Hodgkin lymphoma patent cliff · Low-grade B cell non-Hodgkin lymphoma CI report
- Treatment: Fludara · Nihon Schering K.K.
- Treatment: Fludarabin · Azienda Ospedaliera San Giovanni Battista
- Treatment: Fludara · Celyad Oncology SA
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing